share_log

沃森生物(300142.SZ):九价HPV疫苗与同类疫苗免疫原性比较的Ⅲ期临床试验目前处于数据统计分析和撰写临床研究报告阶段

Watson Biotech (300142.SZ): The phase III clinical trial comparing the immunogenicity of the nine-valent HPV vaccine and similar vaccines is currently in the stage of statistical data analysis and writing clinical research reports

Gelonghui Finance ·  May 14 03:10

GLONGHUI May 14 | Watson Biotech (300142.SZ) held a performance briefing on May 13, 2024 to discuss “When will the nine-cost head-to-head data report on human cancer be released? Is there a time limit?” The company replied that the phase III clinical trial comparing the immunogenicity of the company's nine-valent HPV vaccine and similar vaccines is currently in the stage of statistical data analysis and writing clinical research reports. Please continue to pay attention to the company's information disclosure on related developments.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment